ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.411,55
-0,27%
S&P 500
5.321,41
0,25%
US Dollar vs BRL
5,1233
0,00%
Bitcoin
69.838,99
-0,42%
Brent Oil
82,10
-0,42%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Nautilus Biotechnology Inc (NAUT)

  7. Nautilus Biotechnology Inc (NAUT) Notícias

NAUT

Nautilus Biotechnology (NAUT)

Nautilus Biotechnology Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NAUT
DataHoraFonteTítuloCódigoCompanhia
30/04/202409:00GlobeNewswire Inc.Nautilus Biotechnology Reports First Quarter 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/04/202409:00GlobeNewswire Inc.Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NAUTNautilus Biotechnology Inc
07/03/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAUTNautilus Biotechnology Inc
06/03/202418:39Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NAUTNautilus Biotechnology Inc
05/03/202418:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202410:00GlobeNewswire Inc.Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202409:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202409:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAUTNautilus Biotechnology Inc
28/02/202409:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202409:04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NAUTNautilus Biotechnology Inc
22/02/202410:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
07/02/202410:00GlobeNewswire Inc.Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:NAUTNautilus Biotechnology Inc
30/11/202310:00GlobeNewswire Inc.Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics AwardNASDAQ:NAUTNautilus Biotechnology Inc
01/11/202309:05GlobeNewswire Inc.Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell DevelopmentNASDAQ:NAUTNautilus Biotechnology Inc
31/10/202317:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAUTNautilus Biotechnology Inc
31/10/202309:05GlobeNewswire Inc.Nautilus Biotechnology Reports Third Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/10/202309:05GlobeNewswire Inc.Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023NASDAQ:NAUTNautilus Biotechnology Inc
06/09/202308:30GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming September Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
04/08/202309:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming August Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
02/08/202308:30GlobeNewswire Inc.Nautilus Biotechnology Reports Second Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/07/202310:23GlobeNewswire Inc.Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023NASDAQ:NAUTNautilus Biotechnology Inc
21/06/202307:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NAUTNautilus Biotechnology Inc
24/05/202309:05GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming June Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
02/05/202307:30GlobeNewswire Inc.Nautilus Biotechnology Reports First Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
02/05/202307:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NAUTNautilus Biotechnology Inc
27/04/202317:09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NAUTNautilus Biotechnology Inc
27/04/202317:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NAUTNautilus Biotechnology Inc
18/04/202317:05GlobeNewswire Inc.Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023NASDAQ:NAUTNautilus Biotechnology Inc
23/03/202309:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
07/03/202310:00GlobeNewswire Inc.Nautilus Biotechnology Announces “First Access Challenge” WinnersNASDAQ:NAUTNautilus Biotechnology Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NAUT

Seu Histórico Recente

LSE
LK42
Citi Fun 26
TSXV
RPX
Red Pine Exploration
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados